opc 12759 has been researched along with Adenoma, Prostatic in 1 studies
rebamipide: structure in first source; RN refers to (+-)-isomer; inhibits gastric xanthine oxidase
Excerpt | Relevance | Reference |
---|---|---|
"A large proportion of benign prostatic hyperplasia (BPH) patients suffer from lower urinary tract symptoms after surgery due to the presence of prostatic urothelium wounds." | 1.56 | Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway. ( Cui, X; Deng, Z; Han, B; Jiang, C; Jing, Y; Li, W; Shi, F; Sun, M; Xia, S; Xu, Z; Zhang, W; Zhou, Z, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Sun, M | 1 |
Deng, Z | 1 |
Shi, F | 1 |
Zhou, Z | 1 |
Jiang, C | 1 |
Xu, Z | 1 |
Cui, X | 1 |
Li, W | 1 |
Jing, Y | 1 |
Han, B | 1 |
Zhang, W | 1 |
Xia, S | 1 |
1 other study available for opc 12759 and Adenoma, Prostatic
Article | Year |
---|---|
Rebamipide-loaded chitosan nanoparticles accelerate prostatic wound healing by inhibiting M1 macrophage-mediated inflammation via the NF-κB signaling pathway.
Topics: Alanine; Animals; Cell Proliferation; Chitosan; Dogs; Drug Compounding; Humans; Macrophages; Male; N | 2020 |